# Platelet-Inhibitor Drug Trial in Coronary Angioplasty

> **NCT00000510** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Angina Pectoris
- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Myocardial Ischemia

## Interventions

- **DRUG:** aspirin
- **DRUG:** dipyridamole
- **PROCEDURE:** angioplasty, transluminal, percutaneous coronary

## Key facts

- **NCT ID:** NCT00000510
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1983-09
- **Primary completion:** —
- **Final completion:** 1988-09
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000510, "Platelet-Inhibitor Drug Trial in Coronary Angioplasty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00000510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*